Replies to post #15799 on ANI Pharmaceuticals (ANIP)

[Just the facts maam]

I agree it is ridiculous. ANIP is one of a handful of pharmaceuticals who's revenue topped $10/ share in Q1, quietly sitting on two NDA approvals INZIRQO and TEZRULY, which are now on the market.

Institutions own 107% of the float and are likely trying to trigger stop losses before any announcements.

When a stock hist a 52 week high of $77 due to good new and is driven down 20% in less than two days, it is pure and simple market manipulation by hedge funds, And with a feckless SEC, no one will stop them, so why wouldn't they. It is a rigged game, and all retail investors can do, is take a seat in the back or watch.

GLTA